Skip to main content
. 2020 Sep 24;9(22):8468–8479. doi: 10.1002/cam4.3470

FIGURE 2.

FIGURE 2

OS in 157 patients treated with BR (A) in the entire cohort, (B) in patients with and without 17p‐/TP53 mutation, (C) in patients who had a response to treatment vs patients who did not respond to treatment